Sonic HealthcareSTU:SAB -0.96%69 Days Payable is 163.30 as of Dec. 2025, which is 27% below its 10-year median of 224.81. GuruFocus rates STU:SAB with a GF Score™ of 69/100 and a GF Value™ of €20.08 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Sonic Healthcare ranks better than 80.53% on this metric.
The historical rank and industry rank for Sonic Healthcare's Days Payable or its related term are showing as below:
STU:SAB'
s Days Payable Range Over the Past 10 Years
Min: 197.13 Med: 224.81 Max: 282.16
Current: 202.77
During the past 13 years, Sonic Healthcare's highest Days Payable was 282.16. The lowest was 197.13. And the median was 224.81.
STU:SAB's Days Payable is ranked better than 80.53% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.275
vs STU:SAB: 202.77
Sonic Healthcare's Days Payable
declined
from Dec. 2024 (303.56) to Dec. 2025 (163.30).
It may suggest that Sonic Healthcareaccelerated paying its suppliers.
Sonic Healthcare Days Payable Related Terms
Sonic Healthcare Days Payable Historical Data
* Premium members only.
The historical data trend for Sonic Healthcare's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:SAB vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Sonic Healthcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonic Healthcare Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sonic Healthcare's Days Payable distribution charts can be found below:
* The bar in red indicates where Sonic Healthcare's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sonic Healthcare's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sonic Healthcare (STU:SAB) has a Days Payable of 163.30 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sonic Healthcare and its competitors. This is 27% below median its historical median of 224.81. Over the past decade, Sonic Healthcare's Days Payable has ranged from 197.13 to 282.16. According to the industry distribution chart, Sonic Healthcare ranks #37 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 19.5%.
Is Sonic Healthcare's Days Payable too high?
Sonic Healthcare's current Days Payable of 163.30 is 27% below median its 10-year median of 224.81. Over the past 10 years, this metric has ranged from a low of 197.13 to a high of 282.16. The Medical Diagnostics & Research industry median Days Payable is 67.28. Sonic Healthcare's value of 163.30 is 142.7% above this industry median. Based on the distribution chart, Sonic Healthcare ranks #37 out of 190 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Sonic Healthcare has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonic Healthcare's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Sonic Healthcare ranks #37 out of 190 companies for Days Payable. This places Sonic Healthcare in the top 20% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.28. Sonic Healthcare's value of 163.30 is 142.7% above this benchmark. Historically, Sonic Healthcare's own Days Payable has ranged from 197.13 to 282.16 over the past decade. While the company's 10-year median is 224.81 vs. the industry median of 67.28, Sonic Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 67.28, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sonic Healthcare's current Days Payable of 163.30 is 142.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sonic Healthcare and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 67.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sonic Healthcare's current Days Payable is 163.30, which is 27% below median its own 10-year median of 224.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonic Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sonic Healthcare (STU:SAB) is currently considered Significantly Undervalued. The stock's GF Value™ is €20.08, compared to a current price of €12.57 — trading 37.4% below its estimated fair value. The current Days Payable is 163.30, which is 27% below median its 10-year median of 224.81 and 142.7% above the Medical Diagnostics & Research industry median of 67.28. Sonic Healthcare's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sonic Healthcare (STU:SAB), the current Days Payable is 163.30 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sonic Healthcare (STU:SAB) Overvalued in 2026?
Based on GuruFocus' analysis, Sonic Healthcare stock appears to be undervalued.
The current stock price of €12.57 is trading 37.4% below its estimated GF Value™ of €20.08.
GuruFocus considers Sonic Healthcare to be Significantly Undervalued.
Key valuation signals for STU:SAB:
Days Payable: 163.30 (27% below median its 10-year median of 224.81)
GF Value™: €20.08 vs. price of €12.57 (37.4% below fair value)
Industry Position: 142.7% above the Medical Diagnostics & Research median (#37 of 190)
No single metric tells the full story. See the STU:SAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 35% of group revenue in Australia and New Zealand, 25% in the US, and 40% in Europe.
69GF Score
Get the complete analysis for STU:SAB
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:SAB has been successfully added to your 
